Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Bulgaria Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20142
20151
20171
20201
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AOP Orphan Pharmaceuticals AG2
Takeda2
Amgen1
Loxo Oncology, Inc.1
Novartis Pharmaceuticals1
Seagen Inc.1
Sierra Oncology LLC - a GSK company1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases10
Bone Marrow Diseases5
Myeloproliferative Disorders4
Blood Platelet Disorders3
Hemorrhagic Disorders3
Polycythemia Vera3
Anemia2
Autoimmune Diseases2
Cytopenia2
Hemorrhage2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.